RecallRadar

FDA Device recall Z-0821-2024

Custom procedural convenience kits and trays, gastroenterological & urological, labeled as: AHN BIOPSY STERILE, kit number AHBP12A

On 2024-02-07 the FDA classified a Class II recall of Custom procedural convenience kits and trays, gastroenterological & urological, labeled as: AHN BIOPSY STERILE, kit number AHBP12A by American Contract Systems, citing during an internal investigation, ACS identified that several components were "piggybacked" to ACS trays and subjected to the ACS sterilization process. There is no supporting doc….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0821-2024
ClassificationClass II
Statusongoing
Initiated2023-11-29
Published2024-02-07
Last updated2026-09-13 11:57 UTC
CompanyAmerican Contract Systems
DistributionUS

Product

Custom procedural convenience kits and trays, gastroenterological & urological, labeled as: AHN BIOPSY STERILE, kit number AHBP12A

Reason

During an internal investigation, ACS identified that several components were "piggybacked" to ACS trays and subjected to the ACS sterilization process. There is no supporting documentation stating the "piggybacked" components were assessed to determine if they were suitable for exposure to elevated temperatures for an extended period of time and further exposure to sterilization. As a result, the piggybacked components may (1) have a loss/lack of functionality, (2) loss of drug efficacy, if applicable, and (3) may have had higher than specified EO residuals.

Identifiers

code_infoAHBP12A, UDI/DI 00191072188229, Lot Numbers: 963231, exp. 1/21/2024; 940231, exp. 1/21/2024; 996231, exp. 2/28/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:57 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0821-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.